发明名称 Purinone derivative
摘要 <p>H:/szp/Interwoven/NRPortbl/DCC/SZP/7683959 1docx-21/04/2015 Compounds represented by general formula (I) (all of the symbols in the formula conform to the definitions in the Description) are compounds that, in addition to having a Btk-selective inhibitory activity, exhibit an excellent metabolic stability and can avoid hepatotoxicity or the like, and as a consequence can provide safe therapeutic agents for diseases in which B cells or mast cells participate.</p>
申请公布号 AU2015202128(B2) 申请公布日期 2015.05.28
申请号 AU20150202128 申请日期 2015.04.24
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 YAMAMOTO, SHINGO;YOSHIZAWA, TOSHIO
分类号 C07D473/34;A61K31/522;A61P7/02;A61P29/00;A61P35/00;A61P37/06;A61P43/00 主分类号 C07D473/34
代理机构 代理人
主权项
地址